Compound Evidence File
#EC-2026-0041
BMK methyl glycidate CAS 80532-66-7
Filed under Raw Materials. The bureau holds 150 laboratory returns for this compound from 44 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
44 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 22 May 2026 | 9 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 10.0 | 10.0 | 7 Nov 2025 | 21 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 10.0 | 10.0 | 23 May 2026 | 1 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Feb 2026 | 26 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 13 May 2026 | 11 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 15 Jan 2026 | 4 Apr 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Apr 2026 | 9 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 20 Nov 2025 | 12 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Feb 2026 | 21 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 8 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 20 Jan 2026 | 4 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 18 Jan 2026 | 21 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Feb 2026 | 5 May 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 10.0 | 27 Feb 2026 | 22 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Feb 2026 | 24 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Nov 2025 | 5 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Mar 2026 | 17 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 27 Feb 2026 | 3 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 9.9 | 9.9 | 10.0 | 22 May 2026 | 4 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 9.9 | 11 Dec 2025 | 19 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Feb 2026 | 2 Jun 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.9 | 8.1 | 9.7 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.7 | 6.6 | 10.0 | 21 May 2026 | 21 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 | 21 May 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.4 | 6.9 | 8.7 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.2 | 6.3 | 9.8 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.2 | 6.5 | 9.6 | 24 May 2026 | 24 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 15 | 8.1 | 6.4 | 10.0 | 14 Jan 2025 | 21 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 7.9 | 7.9 | 7.9 | 14 Jan 2025 | 14 Jan 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.7 | 7.7 | 7.7 | 11 Jun 2025 | 11 Jun 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 | 6 May 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 7.1 | 7.1 | 7.1 | 9 Jun 2025 | 9 Jun 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 | 14 Jan 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 6 | 6.1 | 2.9 | 8.9 | 7 May 2025 | 21 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 2 | 6.0 | 5.5 | 6.4 | 28 Mar 2025 | 26 Jan 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 5.8 | 5.8 | 5.8 | 27 Feb 2025 | 27 Feb 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 4.8 | 4.8 | 4.8 | 28 Mar 2025 | 28 Mar 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 4.6 | 4.6 | 4.6 | 20 Jun 2025 | 20 Jun 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 3.6 | 3.6 | 3.6 | 6 May 2025 | 6 May 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 2.8 | 2.8 | 2.8 | 6 May 2025 | 6 May 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 2.7 | 2.7 | 2.7 | 20 Jun 2025 | 20 Jun 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 2.5 | 2.5 | 2.5 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for BMK methyl glycidate CAS 80532-66-7 alone.